These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience. Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845 [TBL] [Abstract][Full Text] [Related]
4. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy]. Yang SM; You JF; Zhang XW; Zheng J; Liao SL Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184 [TBL] [Abstract][Full Text] [Related]
5. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole. Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919 [TBL] [Abstract][Full Text] [Related]
6. Recurrent Androgenetic Complete Hydatidiform Moles with p57 Li MW; Li F; Cheng J; Wang F; Zhou P Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of p57 Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354 [TBL] [Abstract][Full Text] [Related]
8. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes. Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382 [TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population. Osamor JO; Oluwasola AO; Adewole IF J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201 [TBL] [Abstract][Full Text] [Related]
11. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review. Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612 [TBL] [Abstract][Full Text] [Related]
12. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Popiolek DA; Yee H; Mittal K; Chiriboga L; Prinz MK; Caragine TA; Budimlija ZM Hum Pathol; 2006 Nov; 37(11):1426-34. PubMed ID: 16949913 [TBL] [Abstract][Full Text] [Related]
14. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy. Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631 [TBL] [Abstract][Full Text] [Related]
15. Role of P57KIP2 Immunohistochemical Expression in Histological Diagnosis of Hydatidiform Moles. Triratanachat S; Nakaporntham P; Tantbirojn P; Shuangshoti S; Lertkhachonsuk R Asian Pac J Cancer Prev; 2016; 17(4):2061-6. PubMed ID: 27221896 [TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and diagnosis of early hydatidiform mole]. Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459 [No Abstract] [Full Text] [Related]
17. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. LeGallo RD; Stelow EB; Ramirez NC; Atkins KA Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735 [TBL] [Abstract][Full Text] [Related]
19. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656 [TBL] [Abstract][Full Text] [Related]
20. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Jun SY; Ro JY; Kim KR Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]